Becton, Dickinson and Company (BDX) key performance indicators and operating metrics (17 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| International Revenue | 2.09B | FY2026-Q1 |
| Segment revenue | 5.25B | FY2026-Q1 |
| United States Revenue | 3.16B | FY2026-Q1 |
| Diluted Earnings per Share (Adjusted) | 2.91 USD_per_share | FY2026-Q1 |
| SSG&A | 1.39B | FY2026-Q1 |
| Tax Rate | 11.80 percent | FY2026-Q1 |
| Free Cash Flow | 548M | FY2026-Q1 |
| Net leverage | 2.90 ratio | FY2026-Q1 |
| Organic Revenue Growth Rate | 3.90 percent | FY2025-Q4 |
| Average diluted common shares | 287.00 | FY2025-Q4 |
| Interest / Other, net | -181.00 | FY2025-Q4 |
| BD Interventional | 1.33B | FY2025-Q3 |
| BD Life Sciences | 1.25B | FY2025-Q3 |
| BD Medical | 2.93B | FY2025-Q3 |
Back to BDX overview · BDX earnings · BDX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.